The $2.5 Billion PFAS Settlement That Costs About $800 Million

A federal judge on Friday approved more than $2.5 billion in PFAS settlements between New Jersey and four companies — DuPont, Chemours, Corteva, and 3M. The headline number is impressive. It is also the kind of number that only exists inside a settlement document.

The actual present value of all four deals, using the companies' own discount rate, is roughly $785 million. That is not a critique of New Jersey. It is a demonstration of how environmental settlements are priced, and why the headline figure you see in the press release bears the same relationship to economic reality as a bond's face value bears to what someone would actually pay for it today.

Let me walk through the plumbing.

The DuPont, Chemours, and Corteva piece is $875 million in nominal payments spread over 25 years. The settlement agreement itself states the pre-tax present value is approximately $500 million, calculated using an 8 percent discount rate. That discount rate is not a random number pulled from a textbook. It is the same rate the companies can use to prepay the obligation early, which means the settlement effectively gives them a built-in option to buy out the liability at a steep discount. $875 million of future payments, discounted at 8 percent over a quarter-century, becomes roughly half. The gap between the two numbers — nearly $375 million — is just the cost of time, priced at a corporate borrowing rate.

3M's separate settlement is $450 million nominal, $285 million in present value, also paid out over 25 years. Add them up and you get $1.325 billion in total nominal payments and about $785 million in present value. The $2.5 billion figure only materializes if you stack the nominal payment totals on top of remediation costs and a surety-bonded reserve fund that does not actually require any new cash. The press release counts all of them as dollars.

Now, here is where it gets weirder. The settlement creates a $475 million "reserve fund" to guarantee that site remediation happens even if the companies go bankrupt or fail to perform. The reserve fund sounds like a cash escrow. It is not. The settlement documents say it is secured by a surety bond or similar instrument, which means it represents "no new cash outlay by the companies beyond the ongoing costs of maintaining the surety bond." In practice, this is a promise from a third-party insurer to step in if the companies default. The companies pay bond premiums. The public gets a headline about a half-billion-dollar safety net. Both sides are technically telling the truth.

This is basically the same dynamic you see in performance bonds on construction projects. The builder doesn't put cash in the bank; the builder's surety insurer signs a paper saying it will finish the job if the builder walks. The bond cost is a fraction of the face value.

Then there is the insurance shuffle. DuPont and Corteva are buying Chemours' rights to certain PFAS-related insurance proceeds for $150 million. Chemours, the spinoff that inherited most of the legacy chemical operations, gets an upfront payment. DuPont and Corteva get first claim on future insurance recoveries until they recoup the $150 million plus a fee (capped at $35 million). After that, Chemours gets its 50 percent share of any further insurance money. This is an internal rearrangement of who gets to collect from the insurance carriers — the companies' own policyholders — before passing the state its settlement payments.

The cost-sharing split, set by a 2021 memorandum of understanding, assigns Chemours 50 percent of the liability (roughly $250 million in present value), DuPont 35.5 percent, and Corteva 14.5 percent. That split makes sense if you follow the corporate spinoffs: Chemours was carved out of DuPont in 2015 specifically to hold the legacy chemical businesses, then Corteva was spun off in 2019 for the agriculture segment. New Jersey is suing the family tree.

Chemours is in bankruptcy. That matters because it means the 50 percent share of this settlement is being paid by a company that is already working through its creditors. The bankruptcy estate's ability to fund future settlement payments over 25 years is part of the reason the surety-bonded reserve fund exists. (The bankruptcy question also makes the insurance proceeds purchase somewhat ironic: DuPont and Corteva are buying Chemours' insurance rights at a price that assumes those policies are worth something — which is a bet against the market's current view of Chemours' balance sheet.)

The path to Friday's approval was not smooth. New Jersey municipalities and water utilities objected to the original deal, arguing that the state lacked the power to resolve claims that belonged to individual local governments. The state's estimated cost to abate PFAS across the public water system is roughly $5.5 billion. A $2.5 billion nominal settlement — or $785 million in present-value terms — does not even come close to covering that. Carneys Point Township and the Borough of Sayreville formally objected in court, saying the settlement effectively extinguished local claims without local consent.

The resolution was a side deal. In June, New Jersey agreed to dedicate a portion of the settlement funds to local entities and to give wastewater and solid waste utilities releases from cleanup liability. The utilities dropped their objections. Judge Renee Marie Bumb of the federal district court called the settlements "fair, reasonable and adequate" and an "impressive windfall" given litigation risks, and she overruled the remaining municipal objections.

The utilities' release is the real structural bargain here. In exchange for a fraction of the settlement dollars, local water systems give up the right to pursue the companies directly for PFAS-related damages. That's a clean trade from the companies' perspective: convert thousands of potential future claims from individual municipalities into one defined payment schedule.

3M got a similar treatment separately. Its $450 million deal resolves all PFAS liability in New Jersey — sale, marketing, distribution, use, manufacture — while 3M continues to remediate contamination at its own former facilities. And notably, this state settlement sits on top of the nationwide public water system settlement 3M agreed to in 2023, which is separately expected to provide New Jersey water systems approximately $300 million to $500 million. The state settlement and the nationwide settlement are not duplicates; they are layers.

So what is the machine?

It is a liability conversion. The companies trade uncertain, open-ended, potentially unlimited environmental exposure — including future health claims, additional site contamination, and municipal lawsuits — for a fixed 25-year annuity with a known payment schedule. The state trades an uncertain litigation outcome, with all the time, legal costs, and discovery risk that entails, for a defined stream of future payments. Both sides are buying certainty. The headline number is the marketing layer on top of that trade.

The discount rate is where the pricing lives. At 8 percent, a dollar promised in 2041 is worth about 20 cents today. That means the last decade of payments — the 2036 to 2051 window — contributes very little to the present value but accounts for a substantial share of the nominal total. The state gets the headline. The companies get the math.

Whether that math is generous or harsh depends on your view of PFAS litigation risk going forward. If the science and the liability keep expanding, $785 million to resolve all of New Jersey's claims against four of the world's largest PFAS manufacturers is a bargain. If the exposure was already well-understood and bounded, the companies are paying a premium to shut the door.

The stock market, for what it's worth, has already moved on. DuPont is at $142, up 61 percent over the past year. Chemours, the one in bankruptcy, trades around $16. Corteva is at $77. 3M is at $183. None of these prices seem to have been decided by a single New Jersey settlement — partly because these companies are fighting PFAS claims in every state simultaneously, and partly because 25-year payment schedules are hard to price as a one-day event.

The structural point is simpler than the pricing question. New Jersey's settlement turns an unbounded environmental liability into a 25-year annuity, secured by surety bonds, released from municipal challenge, and priced at a corporate borrowing rate. The $2.5 billion figure is the number that fits in a headline. The $785 million figure is the number that fits in a model. The difference between them is the cost of money — and the cost of believing the press release at face value.